Peripheral nerve myelin protein 22/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: <noinclude>{{Subpages}}</noinclude> A nerve protein with potential significance in a number of peripheral neuropathies, either associated with abnormalities of th...) |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
A nerve protein with potential significance in a number of [[peripheral neuropathy|peripheral neuropathies]], either associated with abnormalities of the genotype (e.g., [[Charcot-Marie-Tooth disease]]) or with the presence of anti-PMP22 antibody (e.g., [[hereditary motor and sensory neuropathy type 1a]) | A nerve protein with potential significance in a number of [[peripheral neuropathy|peripheral neuropathies]], either associated with abnormalities of the genotype (e.g., [[Charcot-Marie-Tooth disease]]) or with the presence of anti-PMP22 antibody (e.g., [[hereditary motor and sensory neuropathy type 1a]]) | ||
Latest revision as of 13:23, 31 January 2010
A nerve protein with potential significance in a number of peripheral neuropathies, either associated with abnormalities of the genotype (e.g., Charcot-Marie-Tooth disease) or with the presence of anti-PMP22 antibody (e.g., hereditary motor and sensory neuropathy type 1a)